Direct Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome

Kidney International Reports - United States
doi 10.1016/j.ekir.2018.02.010
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Elsevier BV

Related search

Direct Oral Anticoagulants in Antiphospholipid Syndrome With Venous Thromboembolism: Impact of the European Medicines Agency Guidance

Research and Practice in Thrombosis and Haemostasis
2019English

Adding Herbal Products to Direct-Acting Oral Anticoagulants Can Be Fatal

European Journal of Case Reports in Internal Medicine
Internal Medicine
2019English

Recent Advances in the Treatment of Venous Thromboembolism in the Era of the Direct Oral Anticoagulants

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Development of Treatment of Cancer-Associated Venous Thromboembolism With Direct Oral Anticoagulants

The Japanese Journal of Phlebology
2020English

Direct Oral Anticoagulants (DOACs)

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2015English

Pcv68 - Potential Savings in Highest Prescribing Regions for Direct-Acting Oral Anticoagulants in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Treatment of Venous Thromboembolism With New Oral Anticoagulants

Italian Journal of Medicine
Medicine
2013English

Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2019English

Direct Oral Anticoagulants: First Airbag

Medical Council
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy